Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linyou Zhang

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Journal of Thoracic Disease|August 10, 2023
Bioinformatics analysis and single-cell RNA sequencing: elucidating the ubiquitination pathways and key enzymes in lung adenocarcinomaTong Lu, Ran Xu, Chenghao Wang, et al.
BMC Pulmonary Medicine|March 26, 2022
The MLR, NLR, PLR and D-dimer are associated with clinical outcome in lung cancer patients treated with surgeryJun Wang, Huawei Li, Ran Xu, et al.
Scientific Reports|January 20, 2016
Downregulation of miR-522 suppresses proliferation and metastasis of non-small cell lung cancer cells by directly targeting DENN/MADD domain containing 2DTianze Zhang, Yingying Hu, Jin Ju, et al.
Journal of Cancer Research and Clinical Oncology|July 5, 2023
Development and validation of a nomogram for predicting overall survival of resected N2 non-small cell lung cancer patients undergoing neoadjuvant radiotherapyJiaxin Shi, Bo Peng, Chenghao Wang, et al.
Journal of Cancer Research and Clinical Oncology|July 8, 2023
An anoikis-based gene signature for predicting prognosis in malignant pleural mesothelioma and revealing immune infiltrationJiaxin Shi, Bo Peng, Xiang Zhou, et al.
Cancer Management and Research|October 3, 2019
Downregulated MCOLN1 Attenuates The Progression Of Non-Small-Cell Lung Cancer By Inhibiting Lysosome-AutophagyChuntong Yin, Han Zhang, Xin Liu, et al.
Journal of Thoracic Disease|July 11, 2022
A bioinformatics-based immune-related prognostic index for lung adenocarcinoma that predicts patient response to immunotherapy and common treatmentsChenghao Wang, Tong Lu, Ran Xu, et al.
Annals of Translational Medicine|January 6, 2022
Identification of ubiquitinated substrate proteins and their gene expression patterns in lung adenocarcinomaRan Xu, Tong Lu, Jiaying Zhao, et al.
Frontiers in Immunology|July 19, 2024
Comprehensive analysis of PPP4C's impact on prognosis, immune microenvironment, and immunotherapy response in lung adenocarcinoma using single-cell sequencing and multi-omicsKaiyu Wang, Bo Peng, Ran Xu, et al.
Frontiers in Oncology|May 19, 2023
Preoperative computed tomography-based tumoral radiomic features prediction for overall survival in resectable non-small cell lung cancerBo Peng, Kaiyu Wang, Ran Xu, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Journal of Thoracic Disease|August 10, 2023
Bioinformatics analysis and single-cell RNA sequencing: elucidating the ubiquitination pathways and key enzymes in lung adenocarcinomaTong Lu, Ran Xu, Chenghao Wang, et al.
BMC Pulmonary Medicine|March 26, 2022
The MLR, NLR, PLR and D-dimer are associated with clinical outcome in lung cancer patients treated with surgeryJun Wang, Huawei Li, Ran Xu, et al.
Scientific Reports|January 20, 2016
Downregulation of miR-522 suppresses proliferation and metastasis of non-small cell lung cancer cells by directly targeting DENN/MADD domain containing 2DTianze Zhang, Yingying Hu, Jin Ju, et al.
Journal of Cancer Research and Clinical Oncology|July 5, 2023
Development and validation of a nomogram for predicting overall survival of resected N2 non-small cell lung cancer patients undergoing neoadjuvant radiotherapyJiaxin Shi, Bo Peng, Chenghao Wang, et al.
Journal of Cancer Research and Clinical Oncology|July 8, 2023
An anoikis-based gene signature for predicting prognosis in malignant pleural mesothelioma and revealing immune infiltrationJiaxin Shi, Bo Peng, Xiang Zhou, et al.
Cancer Management and Research|October 3, 2019
Downregulated MCOLN1 Attenuates The Progression Of Non-Small-Cell Lung Cancer By Inhibiting Lysosome-AutophagyChuntong Yin, Han Zhang, Xin Liu, et al.
Journal of Thoracic Disease|July 11, 2022
A bioinformatics-based immune-related prognostic index for lung adenocarcinoma that predicts patient response to immunotherapy and common treatmentsChenghao Wang, Tong Lu, Ran Xu, et al.
Annals of Translational Medicine|January 6, 2022
Identification of ubiquitinated substrate proteins and their gene expression patterns in lung adenocarcinomaRan Xu, Tong Lu, Jiaying Zhao, et al.
Frontiers in Immunology|July 19, 2024
Comprehensive analysis of PPP4C's impact on prognosis, immune microenvironment, and immunotherapy response in lung adenocarcinoma using single-cell sequencing and multi-omicsKaiyu Wang, Bo Peng, Ran Xu, et al.
Frontiers in Oncology|May 19, 2023
Preoperative computed tomography-based tumoral radiomic features prediction for overall survival in resectable non-small cell lung cancerBo Peng, Kaiyu Wang, Ran Xu, et al.
Pageof 7